Chrysosplenol D exhibits significant anti-inflammatory and anticancer properties, making it a compound of interest in pharmaceutical research. It has been studied for its ability to inhibit the growth of various cancer cell lines by inducing apoptosis and suppressing cell proliferation. Its anti-inflammatory effects are linked to the modulation of key signaling pathways such as NF-κB, which plays a central role in inflammation and immune response, including the reduction of cytokine production. Additionally, Chrysosplenol D shows potential as an antioxidant, helping to reduce oxidative stress in cellular models. It also demonstrates antibacterial and antiviral activities at the cellular level. These biological activities suggest possible applications in developing treatments for chronic inflammatory diseases, certain types of cancer, and infectious diseases.